Virginie Joris

Dr. Virginie Joris

MERLN institute, Maastricht University
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
CSCarlos Julio Peniche Silva
Carlos Julio Peniche Silva
RVRodolfo E. De La Vega
Rodolfo E. De La Vega
JPJoseph Panos
Joseph Panos
VJVirginie Joris
Virginie Joris
CEChristopher H. Evans
Christopher H. Evans
Martijn van GriensvenMartijn van Griensven
Martijn van Griensven
MicroRNAs (miRNAs) are short non-coding RNA sequences with the ability to inhibit the expression of a target mRNA at the post-transcriptional level, acting as modulators of both the degenerative and regenerative processes. Therefore, these molecules constitute a potential source of novel therapeutic tools. In this study, we investigated the miRNA expression profile that presented in enthesis tissue upon injury. For this, a rodent enthesis injury model was developed by creating a defect at a rat’s patellar enthesis. Following injury, explants were collected on days 1 (n = 10) and 10 (n = 10). Contra lateral samples (n = 10) were harvested to be used for normalization. The expression of miRNAs was investigated using a “Fibrosis” pathway-focused miScript qPCR array. Later, target prediction for the aberrantly expressed miRNAs was performed by means of the Ingenuity Pathway Analysis, and the expression of mRNA targets relevant for enthesis healing was confirmed using qPCRs. Additionally, the protein expression levels of collagens I, II, III, and X were investigated using Western blotting. The mRNA expression pattern of EGR1, COL2A1, RUNX2, SMAD1, and SMAD3 in the injured samples indicated their possible regulation by their respective targeting miRNA, which included miR-16, -17, -100, -124, -133a, -155 and -182. Furthermore, the protein levels of collagens I and II were reduced directly after the injury (i.e., day 1) and increased 10 days post-injury, while collagens III and X showed the opposite pattern of expression.

31 May 2022 in Cells
Verified
Journal Article
Open access
PDF file
INInês Belo Do Nascimento
Inês Belo Do Nascimento
MVMarie Verfaillie
Marie Verfaillie
GAGamze Ates
Gamze Ates
PBPauline Beckers
Pauline Beckers
VJVirginie Joris
Virginie Joris
EHEmmanuel Hermans
Emmanuel Hermans
Energy homeostasis in the central nervous system largely depends on astrocytes, which provide metabolic support and protection to neurons. Astrocytes also ensure the clearance of extracellular glutamate through high-affinity transporters, which indirectly consume ATP. Considering the role of the AMP-activated protein kinase (AMPK) in the control of cell metabolism, we have examined its implication in the adaptation of astrocyte functions in response to a metabolic stress triggered by glucose deprivation. We genetically modified the astrocyte-like C6 cell line to silence AMPK activity by overexpressing a dominant negative mutant of its catalytic subunit. Upon glucose deprivation, we found that C6 cells maintain stable ATP levels and glutamate uptake capacity, highlighting their resilience during metabolic stress. In the same conditions, cells with silenced AMPK activity showed a reduction in motility, metabolic activity, and ATP levels, indicating that their adaptation to stress is compromised. The rate of ATP production remained, however, unchanged by AMPK silencing, suggesting that AMPK mostly influences energy consumption during stress conditions in these cells. Neither AMPK modulation nor prolonged glucose deprivation impaired glutamate uptake. Together, these results indicate that AMPK contributes to the adaptation of astrocyte metabolism triggered by metabolic stress, but not to the regulation of glutamate transport.

1 February 2025 in The Bone & Joint Journal
Verified
Journal Article
Closed access
PDF file
RGRald Victor Maria Groven
Rald Victor Maria Groven
ÜMÜmit Mert
Ümit Mert
JGJohannes Greven
Johannes Greven
KHKlemens Horst
Klemens Horst
VJVirginie Joris
Virginie Joris
Martijn van GriensvenMartijn van Griensven
Martijn van Griensven
Aims: The aims of this study, using a porcine model of multiple trauma, were to investigate the expression of microRNAs at the fracture site, in the fracture haematoma (fxH) and in the fractured bone, compared with a remote unfractured long bone, to characterize the patterns of expression of circulating microRNAs in plasma, and identify and validate messenger RNA (mRNA) targets of the microRNAs.Methods: Two multiple trauma treatment strategies were compared: early total care (ETC) and damage control orthopaedics (DCO). For this study, fxH, fractured bone, unfractured control bone, plasma, lung, and liver samples were harvested. MicroRNAs were analyzed using quantitative real-time polymerase chain reaction arrays, and the identified mRNA targets were validated in vivo in the bone, fxH, lung, and liver tissue.Results: MicroRNA expression was associated with the trauma treatment strategy and differed depending on the type of sample. In the ETC group, a more advanced fracture healing response, as reflected by the expression of osteogenic microRNAs, was seen compared with the DCO group. DCO treatment resulted in a more balanced immune response in the systemic circulation as represented by significant upregulations of several anti-inflammatory microRNAs. The in vivo validation of the abundance of putative mRNA targets reflected the levels of microRNAs which were identified.Conclusion: Local and systemic microRNA patterns of expression were identified, specific for the treatment strategy in multiple trauma, which corresponded with the expression of mRNA at the fracture site and in target organs. These findings match clinical observations and offer insights into the cellular communication which may underlie the effects of using different surgical strategies in patients with multiple trauma, both locally and systemically. We also identified a systemic involvement of microRNAs in multiple trauma which may include distant cellular communication between injured tissues. Further research may further describe the temporospatial role of circulating microRNAs after multiple trauma, their potential role in communication between organs, and prospective therapeutic applications.Cite this article: Bone Joint J 2025;107-B(2):193–203.

11 August 2023 in Advanced Biology
Verified
Journal Article
Open access
Timo RademakersTimo Rademakers
Timo Rademakers
MSMireille Sthijns
Mireille Sthijns
OFOmar Paulino da Silva Filho
Omar Paulino da Silva Filho
VJVirginie Joris
Virginie Joris
JOJolien Oosterveer
Jolien Oosterveer
VLVanessa LaPointe
Vanessa LaPointe
Oxidative stress leads to a lower success rate of clinical islet transplantation. Here, FDA‐approved compounds are screened for their potential to decrease oxidative stress and to protect or enhance pancreatic islet viability and function. Studies are performed on in vitro “pseudoislet” spheroids, which are pre‐incubated with 1280 different compounds and subjected to oxidative stress. Cell viability and oxidative stress levels are determined using a high‐throughput fluorescence microscopy pipeline. Initial screening on cell viability results in 59 candidates. The top ten candidates are subsequently screened for their potential to decrease induced oxidative stress, and eight compounds efficient reduction of induced oxidative stress in both alpha and beta cells by 25–50%. After further characterization, the compound sulfisoxazole is found to be the most capable of reducing oxidative stress, also at short pre‐incubation times, which is validated in primary human islets, where low oxidative stress levels and islet function are maintained. This study shows an effective screening strategy with 3D cell aggregates based on cell viability and oxidative stress, which leads to the discovery of several compounds with antioxidant capacity. The top candidate, sulfisoxazole is effective after a 30 min pre‐incubation, maintains baseline islet function, and may help alleviate oxidative stress in pancreatic islets.

27 March 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
ASAnika Schumacher
Anika Schumacher
VJVirginie Joris
Virginie Joris
Martijn van GriensvenMartijn van Griensven
Martijn van Griensven
VLVanessa LaPointe
Vanessa LaPointe
Induced pluripotent stem cell (iPSC)–derived kidney organoids have the potential for a large variety of applications. However, they do not persist long in culture, for which reasons are still unclear. Furthermore, their morphological maturation, an essential feature for kidney function, has not been sufficiently assessed. Kidney organoids are transcriptionally much alike end-of-first-trimester fetal kidneys and present many of the same cell types. From large transmission electron microscopy tilescans of specific regions of interest, we compared the ultrastructures of iPSC-derived kidney organoids at various timepoints to human fetal kidneys of the first trimester. Unlike healthy fetal kidneys, large glycogen deposits developed over time in all organoid cell types, but particularly in podocytes and in chondrocytes, one of the off-target populations that contaminate the culture. Deeper investigation showed that glycogen synthase kinase 3b (GSK3β) levels and activation were diminished over time, correlated with the accumulation of glycogen. Activated YAP was strongly expressed and large lipid droplets accumulated over time in proximal tubules. Accordingly, EGFR signaling increased significantly over time. Mitochondria in glomeruli and tubules contained few or no cristae, indicating mitochondrial damage. Together these features are known for hyperglycemic cultures and diabetic nephropathy. Measuring the glucose concentration in the kidney organoid culture medium showed a concentration of 2.94 g/mL, which is considered an elevated, pre-diabetic–like concentration in vitro . In summary, our ultrastructural assessment of iPSC-derived kidney organoids using an age-matched fetal human reference allowed the evaluation of cellular morphology, and we identified intracellular features that can inform the cellular state, which is particularly important while physiological testing of organoids is limited. Translational Statement: Kidney organoids hold promise as a future treatment for patients with end-stage kidney disease. The engineering of kidney organoids with correct and healthy morphology in vitro is therefore essential, to guarantee functionality after transplantation. The present study provided deeper insights into the structural organization and ultrastructure of cells in kidney organoids compared to age-matched human fetal kidneys. Accordingly, we found several features in the regular kidney organoid culture, which are known to occur in hyperglycemic cultures and diabetic nephropathy, indicating that the current medium composition may be inducing pathological cellular phenotypes. This study therefore creates a better understanding of current limitations in the kidney organoid culture, increases knowledge of their function and cellular organization, and sets the foundation for further research to create advanced organoids.

26 December 2025 in Advanced Materials Interfaces
Verified
Journal Article
Open access
FTFilipa C. Teixeira
Filipa C. Teixeira
VJVirginie Joris
Virginie Joris
Martijn van GriensvenMartijn van Griensven
Martijn van Griensven
Lorenzo MoroniLorenzo Moroni
Lorenzo Moroni
Carlos MotaCarlos Mota
Carlos Mota
Spheroids have emerged as valuable tools in bone tissue engineering, mimicking the cellular interactions in native tissues. However, the application of small and low‐cell‐number spheroids for simultaneous bone regeneration and vascularization remains underexplored. In this study, small pre‐vascularized spheroids (250 cells each) were developed, using human mesenchymal stem cells (hMSCs) or human periosteum‐derived stem cells (hPDCs), co‐cultured with human umbilical vein endothelial cells (HUVECs). Spheroids were evaluated for stability, osteogenic differentiation, and angiogenic potential. Results indicated that hMSC and hPDC spheroids formed stable structures, while HUVEC monocultures failed to achieve spheroid stability. Co‐cultures showed HUVEC localization patterns mimicking native vascular structures. Gene and protein analyses revealed distinct osteogenic potential between hMSC and hPDC spheroids, with the latter demonstrating superior and earlier differentiation. Additionally, vascular endothelial growth factor expression was higher in co‐cultures, suggesting enhanced angiogenic potential, particularly in hPDC spheroids. Using small‐diameter spheroids addresses limitations of conventional large spheroids, such as necrotic core formation and heterogeneous differentiation. These findings emphasize the promise of pre‐vascularized spheroids for scaffold‐free and scaffold‐based tissue engineering applications. Furthermore, their small size enables the exploration of their potential applications in 3D bioprinting, paving the way for the future development of more biomimetic vascularized bone constructs.